Investor Relations

Press Releases

Press Releases

Nov 17, 2019
Karuna Therapeutics Schedules Webcast and Conference Call to Announce Results from its Phase 2 Clinical Trial of KarXT for the Treatment of Psychosis in Patients with Schizophrenia
BOSTON --(BUSINESS WIRE)--Nov. 17, 2019-- Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today
Aug 28, 2019
Karuna Therapeutics to Present at Upcoming Investor Conferences
BOSTON --(BUSINESS WIRE)--Aug. 28, 2019-- Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced that members of its senior management team are scheduled
Displaying 1 - 10 of 16
Top